Medical experts convening at the American Neurology Association meeting to evaluate phase 3 Alzheimer's data on a drug from Eli Lilly. CNBC's Seema Mody reports.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT